MR in Drug Research Study Group
Tuesday, 21 May 2002
Room 315
19:30 - 21:30

Business Meeting
Scientific Meeting

How MRI Helps the Drug Industry Discover and Develop More Valuable Medicines Faster
John C. Waterton, Ph.D., AstraZeneca, Cheshire, England, UK

What's Needed for DCEMRI in Trials of Drugs Targeted at the Vasculature
Martin O. Leach, Ph.D., Institute of Cancer Research, England, UK
Discussion Period